Immediate Angicoagulation for Acute Stroke in Atrial Fibrillation: No
Stroke 37:3054-3055,3056, Sandercock,P., 2006
Use of Single and Combined Antithrombotic Therapy and Risk of Serious Upper Gastrointestinal Bleeding: Population Based Case-Control Study
BMJ 333:726-728, Hallas,J.,et al, 2006
Warfarin vs Aspirin for Symptomatic Intracranial Stenosis: Subgroup Analyses from WASID
Neurol 67:1275-1278, Kasner,S.E.,et al, 2006
Management of Antiphospholipid Antibody Syndrome, A Systematic Review
JAMA 295:1050-1057, Lim,W.,et al, 2006
Clopidogrel Plus Aspirin Versus Oral Anticoagulation for Atrial Fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): A Randomised Controlled Trial
Lancet 367:1903-1912,1877, The ACTIVE Writing Group on behalf of the ACTIVE Investigators, 2006
Intracerebral Hemorrhage
The Neurologist 11:311-324, Badjatia,N. &Rosand,J., 2005
Treatment-Responsive Limbic Encephalitis Identified by Neuropil Antibodies: MRI and PET Correlates
Brain 128:1764-1777, Ances,B.M., et al, 2005
Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005
Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis
NEJM 352:1305-1316, 1368, Chimowitz,M.I.,et al, 2005
Extracranial Arterial Dissection, Angicoagulation Is the Treatment of Choice: Against
Stroke 36:2042-2043,2043, Lyrer,P.A., 2005
Antithrombotic Drugs for Carotid Artery Dissection
Stroke 25:613-614, Lyrer,P.&Engelter,S., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Prescription of Antithrombotic Therapy in Older Patients Hospitalized for Transient Ischemic Attack and Ischemic Stroke:The GIFA Study
Stroke 35:913-917, Volpato,S.,et al, 2004
Age As a Determinant of Adverse Events in Medically Treated Cryptogenic Stroke Patients with Patent Foramen Ovale
Stroke 35:2145, Homma,S.,et al, 2004
Combined Anticoagulant-Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
Stroke 35:2362-2367, Shireman,T.I.,et al, 2004
Stiff-Person Syndrome
The Neurologist 10:131-137, Murinson,B.B., 2004
Risks and Benefits of Anticoagulant and Antiplatelet Medication Use Before Cataract Surgery
Ophthalmology 110:1784-1788, Katz,J.,et al, 2003
Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Mayo Clin Proc 78:1392-1396, Otley,C.C., 2003
Autoantibodies to Glutamic Acid Decarboxylase in Downbeat Nystagmus
JNNP 74:998-999, Antonini,G.,et al, 2003
Glutamic Acid Decarboxylase Autoantibodies and Neurological Disorders
Neurol Sci 23:145-151, Vianello,M.,et al, 2002
Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002
New Evidence for Stroke Prevention
JAMA 288:1388-1395, Straus,S.E.,et al, 2002
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
JAMA 288:2441-2448, van Walraven,C.,et al, 2002
Encephalitis Associated with Glutamic Acid Decarboxylase Autoantibodies
Neurol 56:814, Marchiori,G.C.,et al, 2001
A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke
NEJM 345:1444-1451,1493, Mohr,J.P.,et al, 2001
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001
High-dose Intravenous Immune Globulin for Stiff-person Syndrome
NEJM 345:1870-1876, Dalakas,M.B.,et al, 2001
Cerebellar Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies
Arch Neurol 58:225-230, Honorat,J.,et al, 2001
Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001
Folic Acid Antagonists During Pregnancy and the Risk of Birth Defects
NEJM 343:1608-1614, Hernandez-Dias,S.,et al, 2000
The Clinical Spectrum of Anti-GAD Antibody-Positive Patients with Stiff-Person Syndrome
Neurol 55:1531-1535, Dalakas,M.C.,et al, 2000
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Primary Prevention of Arterial Thromboembolism in Non-Rheumatic Atrial Fibrillation in Primary Care:Randomised Controlled Trial Comparing Two Intensities of Coumarin with Aspirin
BMJ 319:958-964, Hellemons,B.S.P.,et al, 1999
Antithrombotic Therapy to Prevent Stroke in Patients with Atrial Fibrillation:A Meta-Analysis
Ann Int Med 131:492-501,537, Hart,R.G.,et al, 1999
Secondary Prevention after Cerebral Ischaemia of Presumed Arterial Origin:Is Aspirin Still the Touchstone?
JNNP 66:557-559, Algra,A.,et al, 1999
Frequency of Major Complications of Aspirin,Warfarin,and Intravenous Heparin for Secondary Stroke Prevention,A Population-Based Study
Ann Int Med 130:14-22, Petty,G.W.,et al, 1999
Preventing Stroke in Patients with Atrial Fibrillation
JAMA 281:1830-1835, Ezekowitz,M.D.&Levine,J.A., 1999
Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Neurol 51:674-681, Hart,R.G.,et al, 1998
Stroke Prevention in Patients with Nonvascular Atrial Fibrillation
Qual Stds Subcom AAN, Neurol 51:671-6731998., , 1998
Differences in Medical & Surgical Therapy for Stroke Prevention Between Experts in N. America & Europe
Stroke 29:339-345, Masuhr,F.,et al, 1998
Stiff-Leg Syndrome:A Focal Form of Stiff-Man Syndrome
Ann Neurol 43:400-403, Saiz,A.,et al, 1998
Fixed Minidose Warfarin & Aspirin Alone & in Comb vs Adjusted-Dose Warfarin for Stroke Prevent in Atrial Fib
Arch Int Med 158:1513-1521, 14871998., Gullov,A.L.,et al, 1998
Pts with Nonvalvular Fib at Low Risk of Stroke During Trtm with Aspirin
Stroke Prevent in A Fib, SPAF III Cmte for Stroke Prevent, JAMA 279:1273-1277998., , 1998
Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998
Wernicke's Encephalopathy:An Excitotoxicity Hypothesis
Metabolic Brain Disease 12:183-192, McEntee,W.J., 1997
Ventricular Dysfunction and the Risk of Stroke After Myocardial Infarction
NEJM 336:251-257, Loh,E.,et al, 1997
A Randomized Trial of Anticoagulants Vs Aspirin After Cerebral Ischemia of Presumed Arterial Origin
SPIRIT Study Group, Ann Neurol 42:857-8651997., , 1997